alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2004199EN.01000301.xml

| 6.8.2004 | EN | Official Journal of the European Union | C 199/3 |
| --- | --- | --- | --- |

6.8.2004

EN

Official Journal of the European Union

C 199/3

---

Non-opposition to a notified concentration

(Case No COMP/M.3477 — LAND NRW/NRW BANK)

(2004/C 199/04)

(Text with EEA relevance)

On 27 July 2004, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EEC) No 4064/89. The full text of the decision is available only in German and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/) free of charge. This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/) free of charge. This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form in the ‘CEN’ version of the CELEX database, under document number 304M3477. CELEX is the computerized documentation system of European Community law. For more information on how to access Celex, see ‘subscriber information’ links below: |
| --- | --- |

—

in electronic form in the ‘CEN’ version of the CELEX database, under document number 304M3477. CELEX is the computerized documentation system of European Community law. For more information on how to access Celex, see ‘subscriber information’ links below:

CELEX: subscriber information

http://publications.eu.int/general/en/eulaw_en.htm

---
In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS

No. 12-616V

Filed: August 22, 2014

Not for Publication

*************************************

JESSICA HANSON, *

*

 Petitioner, * Attorneys’ fees and costs decision based on

 * stipulation of facts

v. *

 *

SECRETARY OF HEALTH *

AND HUMAN SERVICES, *

 *

 Respondent. *

*

*************************************

Ronald C. Homer, Boston, MA, for petitioner.

Darryl R. Wishard, Washington, DC, for respondent.

MILLMAN, Special Master

DECISION AWARDING ATTORNEYS’ FEES AND COSTS1

On August 22, 2014, the parties filed a stipulation of facts in which they agreed on an 

appropriate amount for attorneys’ fees and costs in this case. 

Petitioner filed an application for attorneys’ fees and costs on August 19, 2014. During 

informal discussions, respondent raised objections to certain items in petitioner’s application. 

Based on these objections, petitioner amends her application to request $39,250.00 for attorneys’ 

 

1 Because this unpublished decision contains a reasoned explanation for the special master’s action in this 

case, the special master intends to post this unpublished decision on the United States Court of Federal 

Claims’s website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 2899, 

2913 (Dec. 17, 2002). Vaccine Rule 18(b) states that all decisions of the special masters will be made 

available to the public unless they contain trade secrets or commercial or financial information that is 

privileged and confidential, or medical or similar information whose disclosure would constitute a clearly 

unwarranted invasion of privacy. When such a decision is filed, petitioner has 14 days to identify and 

move to redact such information prior to the document=s disclosure. If the special master, upon review, 

agrees that the identified material fits within the banned categories listed above, the special master shall 

redact such material from public access.
2

fees and costs and $38.00 for petitioner’s costs. Respondent does not object to these amounts. 

The undersigned finds these amounts to be reasonable. Accordingly, the court awards:

a. $39,250.00, representing reimbursement for attorneys’ fees and costs. The 

award shall be in the form of a check payable jointly to petitioner and Conway, 

Homer & Chin-Caplan, P.C. in the amount of $39,250.00; and

b. $38.00, representing reimbursement for petitioner’s costs. The award shall be 

in the form of a check payable to petitioner in the amount of $38.00.

In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the 

court is directed to enter judgment herewith.2

IT IS SO ORDERED.

Dated: August 22, 2014 s/ Laura D. Millman

 Laura D. Millman

 Special Master

 

2

Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party, either separately or 

jointly, filing a notice renouncing the right to seek review.
<PAGE>

                                                                    EXHIBIT 32.1

                WRITTEN STATEMENT OF THE CHIEF EXECUTIVE OFFICER
                          PURSUANT TO 18 U.S.C. SS.1350

         Solely for the purposes of complying with 18 U.S.C. ss.1350, I, the
undersigned Chief Executive Officer of Z-Tel Technologies, Inc. (the "Company"),
hereby certify, based on my knowledge, that the Quarterly Report on Form 10-Q of
the Company for the quarterly period ended March 31, 2004 (the "Report") fully
complies with the requirements of Section 13(a) of the Securities Exchange Act
of 1934 and that information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

/s/ D. Gregory Smith
-------------------------------------
D. Gregory Smith
May 17, 2004

         A signed original of this written statement has been provided to Z-Tel
Technologies, Inc. and will be retained by the Z-Tel Technologies, Inc. and
furnished to the Securities and Exchange Commission or its staff upon request.
Sylvia Soto, Individually and as Representative of the Estate



# Fourth Court of Appeals **San Antonio, Texas**

March 4, 2014

N o. 04

- 13

- 00822

- CV

WILLIAMSBURG CARE COMPANY L.P. d/b/a Princeton Place Rehabilitation and Healthcare, Appellant

v.
Sylvia SOTO , Individually and as Representative of the Estate of Narcisa Dimas, Deceased, Ruby Buentello, Individually and as Representative of the Estate of Manuel Riojas Munoz, Deceas ed, and Adela Barboza, Individually, Appellee s
From the 150th Judicial District Court, Bexar County, Texas Trial Court No. 2013

- CI

- 05792 Honorable John D. Gabriel, Jr., Judge Presiding



### ORDER

Appellant has filed a motion to abate th is appeal because one of the issues presented in the appeal is the same issue pending in petitions for review filed in Williamsburg Care Co. L.P. v. Acosta , 406 S.W.3d 711 (Tex. App.

— San Antonio 2013, pet. filed), Fredericksburg Care Co. L.P. v. Lira , 407 S.W.3d 810 (Tex. App.

— San Antonio 2013, pet. filed), and Fredericksburg Care Co. L.P. v. Perez , 406 S.W.3d 313 (Tex. App.

— San Antonio 2013, pet. filed). T his court has considered the motion, the appellees’ response, and the appellant’s reply to the appellees’
response. In light of the pending higher court review of the precedent previously established by this court, the court has determined that abating th is appeal pending the Texas Supreme Court’s resolution of the issue will likely achieve the greatest judicial efficiency. Accordingly, appellant’s motion to abate is GRANTED. For administrative purposes, th is appeal will be treated as a closed case, unle ss and until appellant files a motion requesting its reinstatement following the Texas Supreme Court’s resolution of the issue

.

_________________________________ Karen Angelini, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said court on this 4th day of March, 2014

.

___________________________________ Keith E. Hottle Clerk of Court
**Exhibit 23.1**

**Consent of Independent Registered Public Accounting Firm**

The Shareholders

Mad Catz Interactive, Inc.: 

We consent to incorporation by reference in the registration statement (No. 333-103798) on Form S-8 of Mad Catz Interactive, Inc. of our report dated May 26, 2006, except for paragraph 5 of note 9, which is as of June 23, 2006,relating to the consolidated balance sheets of Mad Catz Interactive, Inc. and subsidiaries as of March 31, 2006 and 2005, and the related consolidated statements of operations, stockholders’ equity and comprehensive income and cash flowsfor each of the years in the three-year period ended March 31, 2006, and the related financial statement Schedule II, which report appears in the March 31, 2006 Annual Report on Form 10-K of Mad Catz Interactive, Inc. 

/s/ KPMG LLP 

San Diego,California 

June 28, 2006
December 23, 2013

Mr. Jason Cabot

388 Beale St, Apt 1407

San Francisco, CA 94105

Dear Mr. Cabot, 

This is in response to your September 4, 2013 letter, requesting an amendment to Title 14, 

Code of Federal Regulations (14 CFR) § 91.187, Operations under Instrument Flight Rules 

(IFR) in controlled airspace: Malfunction reports. Specifically, your letter requested an 

amendment to the requirement for the pilot in command of an aircraft operating under IFR to 

report any malfunctions of navigational, approach, or communication equipment to ATC. 

When the FAA responds to petitions for rulemaking, it must follow the requirements outlined

in 14 CFR part 11, General Rulemaking Procedures. As stated in § 11.73, the FAA uses the 

following criteria when making a decision as to whether or not to amend current regulations 

based on a petition for rulemaking: 

1) the immediacy of the safety or security concerns the petition raises;

2) the priority of other FAA issues; and

3) the resources we have available to address these issues.

While the issues raised in your petition may have merit, they do not address an immediate 

safety concern. Therefore, your request is denied. Your comment and reasons for a rule 

change will be considered if the agency undertakes future rulemaking in this area. 

Accordingly, Docket No. FAA-2013-0783 is being closed.

/s/

Lirio Liu

Director, Office of Rulemaking
**Exhibit 23.2**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMWe consent to the incorporation by reference in Registration Statements (No. 333-108225,333-132716) on Form S-3 of our reports dated February 27, 2007,relating to (1) the 2006 and 2005 financial statements and theretrospective adjustments to the 2004 financial statement disclosuresof Bottling Group, LLC and subsidiaries and (2) the financialstatement schedule for 2006 and 2005 of Bottling Group, LLC andsubsidiaries, appearing in this Annual Report on Form 10-K ofBottling Group, LLC and subsidiaries for the year endedDecember 30, 2006 (which reportsexpress unqualified opinions and which report on the 2006 and 2005 financial statements includes explanatoryparagraphs referring to the Company’s adoption of Statements of Financial Accounting Standards No.123(R), “Share-Based Payment,” and No. 158, “Employers’ Accounting for Defined BenefitPension and Other Postretirement Plans — an amendment of FASB Statements No. 87, 88, 106, and132(R),” related to the requirement to recognize the fundedstatus of a benefit plan).
EXHIBIT 31.1
SECTION 302 CERTIFICATION
OF CHIEF EXECUTIVE OFFICER

I, George Tsafalas, Chief Executive Officer of Fairchild International Corporation, certify that:

1.	I have reviewed this Quarterly Report on Form 10-QSB of Fairchild International Corporation;

2.	Based on my knowledge, this  report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

1. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
2. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
3. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the small business issuer's most recent fiscal quarter (the small business issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer's internal control over financial reporting; and

1. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

1. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
2. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 12, 2004

/s/ George Tsafalas

_____________________________
George Tsafalas, President
and Chief Executive Officer
# C_2004223EN.01002001.xml

| 7.9.2004 | EN | Official Journal of the European Union | C 223/20 |
| --- | --- | --- | --- |

7.9.2004

EN

Official Journal of the European Union

C 223/20

---

Non-opposition to a notified concentration

(Case No COMP/M.3528 — SWISS RE/LAHC)

(2004/C 223/04)

(Text with EEA relevance)

On 20 August 2004, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/) free of charge. This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/) free of charge. This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form in the ‘CEN’ version of the CELEX database, under document number 32004M3528. CELEX is the computerized documentation system of European Community law. (http://europa.eu.int/celex) |
| --- | --- |

—

in electronic form in the ‘CEN’ version of the CELEX database, under document number 32004M3528. CELEX is the computerized documentation system of European Community law. (http://europa.eu.int/celex)

---
IN THE SUPREME COURT OF THE STATE OF DELAWARE

WALTER E. RYAN, JR. and RYAN

ASSET MANAGEMENT, LLC on 

Behalf of Themselves and All Others 

Similarly Situated,

Plaintiffs Below, 

Appellants,

v.

TRACY ACCARDI, JAMES R. 

BERGMAN, JOSEPH R. 

BRONSON, TUNC DOLUCA, 

ROBERT E. GRADY, MERCEDES 

JOHNSON, WILLIAM P. 

SULLIVAN, WILLIAM D. 

WATKINS, MARYANN WRIGHT, 

and ANALOG DEVICES, INC.,

 

Defendants Below, 

 Appellees. 

 §

 § No. 224, 2023

 §

 § Court Below—Court of

 § Chancery of the State of

 § Delaware

 § 

 § C.A No. 2022-0255

 § 

 §

 §

 §

 §

 §

 §

 §

 §

 §

 §

 §

 §

Submitted: February 14, 2024

Decided: February 26, 2024

Before TRAYNOR, LEGROW, and GRIFFITHS, Justices.

ORDER

This 26

th day of February 2024, after careful consideration of the parties’ 

briefs and the record below, and following oral argument, we find it evident that the

judgment of the Court of Chancery should be affirmed on the basis of and for the 

reasons stated in its May 2, 2023 order and transcript ruling granting appellees’
2

motion to dismiss appellants’ complaint and its May 30, 2023 order denying 

appellants’ motion for reargument.

NOW, THEREFORE, IT IS ORDERED that the judgment of the Court of 

Chancery is AFFIRMED.

BY THE COURT:

/s/ N. Christopher Griffiths

 Justice
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 By Notice dated February 5, 2009, and published in the 
                    **Federal Register**
                     on February 11, 2009 (74 FR 6920), Roche Diagnostics Operations Inc., Attn: Regulatory Compliance, 9115 Hague Road, Indianapolis, Indiana 46250, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedules I and II: Drug
ScheduleLysergic acid diethylamide (7315)
ITetrahydrocannabinols (7370)
IAlphamethadol (9605)
ICocaine (9041)
IIEcgonine (9180)
IIMethadone (9250)
IIMorphine (9300)
II
 The company plans to import the listed controlled substances for the manufacture of diagnostic products for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of Roche Diagnostics Operations Inc. to import the basic classes of controlled substances is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Roche Diagnostics Operations Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: April 17, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.


[FR Doc. E9-9784 Filed 4-28-09; 8:45 am] BILLING CODE 4410-09-P
[Federal Register Volume 74, Number 79 (Monday, April 27, 2009)]
[Notices]
[Page 19041]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-9483]


-----------------------------------------------------------------------

DEPARTMENT OF AGRICULTURE

National Agricultural Statistics Service


Notice of Intent To Suspend the Distiller's Grains Survey and 
Reports

AGENCY: National Agricultural Statistics Service, USDA.

ACTION: Notice of suspension of data collection and publication.

-----------------------------------------------------------------------

SUMMARY: This notice announces the intention of the National 
Agricultural Statistics Service (NASS) to suspend a currently approved 
information collection, the Distiller's Grains Survey, and its 
associated publication.

FOR FURTHER INFORMATION CONTACT: Joseph T. Reilly, Associate 
Administrator, National Agricultural Statistics Service, U.S. 
Department of Agriculture, (202) 720-4333.

SUPPLEMENTARY INFORMATION:
    Title: Distiller's Grains Survey.
    OMB Control Number: 0535-0247.
    Expiration Date of Approval: August 31, 2009.
    Type of Request: To suspend a currently approved information 
collection.
    Abstract: The primary objective of the National Agricultural 
Statistics Service is to prepare and issue State and national estimates 
of crop and livestock production, disposition, and prices. The 
Distiller's Grains Survey was conducted as a one time only survey to 
gather information for establishing a baseline measure of the current 
usage of distiller's grains and identify any barriers hindering 
livestock producers from utilizing distiller's grains and other ethanol 
by-products in their feed rations. NASS will suspend this information 
collection as of April 27, 2009 due to the completion of the survey.

    Authority:  These data were collected under authority of 7 
U.S.C. 2204(a). Individually identifiable data collected under this 
authority are governed by Section 1770 of the Food Security Act of 
1985, 7 U.S.C. 2276, which requires USDA to afford strict 
confidentiality to non-aggregated data provided by respondents.

    Estimate of Burden: There will be no further public reporting 
burden for this collection of information.

    Signed at Washington, DC, March 27, 2009.
Joseph T. Reilly,
Associate Administrator.
[FR Doc. E9-9483 Filed 4-24-09; 8:45 am]
BILLING CODE 3410-20-P